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1. Capsaicin-sensitive sensory nerves and neurogenic inflammation 
The subpopulation of capsaicin-sensitive sensory nerves are composed of primary sensory afferents 
of the dorsal root and trigeminal ganglia expressing the Transient Receptor Potential Vanilloid 1 
(TRPV1) receptor. These polymodal nociceptors possess three different functions (Szolcsányi, 1996). 
Their classical afferent function is the mediation of sensory inputs towards the central nervous 
system, resulting in pain sensation. The local efferent function is the formation of neurogenic 
inflammation through the release of proinflammatory neuropeptides (calcitonin gene-related peptide 
(CGRP) and tachykinins) from the peripheral nerve endings, leading to vasodilatation, plasma protein 
extravasation and activation of inflammatory cells (Szolcsányi, 1988). Due to the systemic efferent 
function, antiinflammatory neuropeptides (e.g. somatostatin, PACAP) are also released, reaching the 
systemic circulation and exerting antiinflammatory and analgesic effects in distinct parts of the body 
(Szolcsányi et al., 1998). TRPV1 is a polymodal cation channel that can be gated by noxious heat 
(>43°C), high proton concentration (pH<6), plant-derived vanilloids (e.g. capsaicin, resiniferatoxin) 
and endogenous agonists (e.g. anandamide, arachidonic acid metabolites) (Tominaga et al., 1998; 
Yoo és mtsai., 2014). Other compounds (e.g. bradykinin, prostaglandins) are able to sensitize the 
TRPV1 by acting on their own receptor (Szallasi és mtsai., 2007). The activation of the receptor 
causes Na+- and Ca2+-influx, resulting in membrane depolarization and consequent formation of 
action potential and the release of sensory neuropeptides from nerve endings, respectively. 
 
2. Transient Receptor Potential Ankyrin 1 (TRPA1) receptor 
Another member of the TRP receptor family, the Transient Receptor Potential Ankyrin 1 (TRPA1) is 
also expressed on capsaicin-sensitive sensory fibres (Jaquemar et al., 1999). TRPA1 is often 
colocalized with the TRPV1 receptor, as well as with CGRP and substance P (SP) (Julius, 2013; Chen 
et al., 2012). Recently, the non-neural expression of TRPA1 has also been descibed, e.g. on 
fibroblasts, keratinocytes, macrophages and the endothelial cells of cerebral arteries (Fernandes et al., 
2012). The exogenous agonists of TRPA1 are several plant-derived compounds, such as 
allylisothiocyanate (AITC, the pungent agent of mustard oil) and cinnamaldehyde (Jordt et al., 2004; 
Macpherson et al., 2006), but also certain toxic gases, such as crtotonaldehyde and acrolein found in 
cigarette smoke (Bautista és mtsai., 2006; André et al., 2008). It is important to note, that numerous 
endogenously formed compounds, such as reactive oxygen species (ROS) and several lipid 
peroxydation products (e.g. 4-hydroxynonenal (HNE), 4-oxo-2-nonenal (4-ONE)) are able to 
stimulate the TRPA1 (Trevisani et al., 2007;Graepel et al., 2011). Among the physical activators of 
the receptor, the role of mechanical stimuli and noxious cold (<17°C) has been proposed (Story et al., 
2003; Jordt et al., 2004; Brierley et al., 2011). The TRPA1 receptor is a ligand-gated non-selective 
cation channel, the activation of which occurs through the binding of the agonists to the N-terminal 
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cysteine residues. This results in conformation changes and the opening of the ion channel, followed 
by the depolarization of the cell membrane and the elevation of the intracellular Ca2+-level 
(Macpherson et al., 2007; Chen and Hackos, 2015). The subsequent release of SP and CGRP produces 
neurogenic inflammation (Trevisani et al., 2007). Several activators of the TRPA1 has been suggested 
to elicit vasodilatation, e.g. cinnamaldehyde and acrolein, as well as the endogenous 4-ONE (Pozsgai 
et al., 2010; Kunkler et al., 2011; Graepel et al., 2011). Moreover, TRPA1 plays a key role in the 
development of cold-induced vascular response (Aubdool et al., 2014). However, the precise 
mechanisms of the vasodilatory effect of TRPA1 is currently unknown (Earley, 2012). Another 
important role of the TRPA1 is the formation of physiological reactions to airway irritants (Bessac 
and Jordt, 2008). The acute inhalation of toxic compounds induces protective reflexes (e.g. cough), 
but the permanent stimulation of the receptor by endogenous activators produced in inflammatory 
processes results in further release of neurotransmitters and cytokines (Chen et al., 2012). Moreover, 
the mediator role of TRPA1 has also been suggested in certain effects induced by bacterial endotoxins 
(Meseguer et al., 2014). Therefore, investigating the function of the TRPA1 receptor is highly 
reasonable not only in local microcirculation, but also in acute and chronic inflammatory processes 
of the respiratory system. 
 
3. Neuropeptides released from capsaicin-sensitive nerve endings: CGRP and tachykinins 
CGRP is a 37-amino acid peptide, which exists in two isoforms: α-CGRP, found predominantly in 
the central and peripheral nervous system, and β-CGRP, being present mainly in the enteric nervous 
system. The expression of CGRP has also been described in non-neuronal cells, e.g. immune- and 
endothelial cells (Russell et al., 2014). The CGRP receptor is a heterodimeric complex composed of 
two peptide molecules (CLR-RAMP1) (Barwell et al., 2012). CGRP is released from the peripheral 
endings of dorsal root and trigeminal ganglia neurons upon stimulation, and its major role is the 
regulation of microcirculation. CGRP is an extremely potent vasodilator molecule, exerting its effects 
predominantly in the skin and the trigeminal system, that are the main anatomical targets of the 
peptide (Brain and Cox, 2006). 
The family of tachykinins includes the Tac1 gene-encoded SP and neurokinin A (NKA), the Tac3-
gene-derived neurokinin B (NKB), as well as the Tac4 gene-encoded hemokinins and endokinins 
(Steinhoff et al., 2014). The effects of the tachykinins are mediated by three identified G-protein-
coupled receptors: the neurokinin 1 (NK1), the neurokinin 2 (NK2) and the neurokinin 3 (NK3) 
receptors. SP shows the greatest affinity to the NK1 receptor, whereas NKA binds predominantly to 
the NK2, and NKB to the NK3 receptor (Maggi, 1995). The best known central effect of SP - expressed 
mainly in the capsaicin-sensitive primary afferents but also found in several immune cells – is the 
modulation of pain sensation (Zubrzycka and Janecka, 2000). The peripheral actions of SP include 
plasma protein extravasation, leukocyte infiltration and mast cell degranulation during neurogenic 
inflammation (Grant, 2002). These effects occur through the activation the NK1 receptors found on 
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endothelial and inflammatory cells (Cao et al., 1999). NKA causes plasma protein extravasation, 
smooth muscle contraction and activation of inflammatory cells (de Swert and Joos, 2006). The Tac4 
gene was cloned in 2000, and it encodes several related peptides in different species: hemokinin-1 
(HK-1) in mice and rats, as well as human HK-1 (hHK-1) and the group of endokinins (EKA, EKB, 
EKC, EKD) in humans (Zhang et al., 2000; Page, 2004). HK-1 binds predominantly to the NK1 
receptor (Bellucci et al., 2002), moreover, it also shows structural similarities to SP resulting in strong 
immunological crossreactivity with anti-SP antibodies (Page, 2004). However, numerous effects 
induced by HK-1 differ from those of SP. This feature might be explained by the hypothesis that 
certain actions of HK-1 are not mediated by the NK1 receptor (Endo et al., 2006). Unlike classical 
tachykinins, HK-1 is mainly expressed in non-neural tissues (Duffy et al., 2003), such as B- and T-
cells, macrophages and dendritic cells, suggesting its possible role in inflammatory processes. 
According to previous results of our workgroup, SP and NKA play an important role in the 
development of acute pneumonitis (Helyes et al., 2010), however, it is also known, that the expression 
level the Tac4 gene is remarkably higher in the lung than that of the Tac1 (Duffy et al., 2003). The 
fact, that the structural and immunological similarities of SP and HK-1 impede to make a correct 
distinction between the specific functions of the two peptides, has raised the possibility that the group 
of hemokinins and endokinins may be the missing link in the pathophysiological mechanism of 
tachykinin-mediated pro-inflammatory actions. 
 
4. The relationship between hydrogen-sulfde and the capsaicin-sensitive sensory neurons 
Hydrogen-sulfide (H2S) is the third known gaseous mediator of the mammalian organism beside nitric 
oxide (NO) and carbon monoxide (CO) (Wang R, 2012). In the recent years, knowledge has increased 
concerning the biological functions of H2S with established activities in the cardiovascular system 
and in inflammatory processes (Kimura, 2014). Although the molecular targets of H2S are not 
precisely clarified, it has been proposed that ion channels (e.g. K+ATP-channels) might participate in 
the vasodilatory actions of the gasotransmitter (Liang et al., 2011). The relation between H2S and the 
capsaicin-sensitive primary afferents was first shown in the lung (Prior et al., 1990). Later, it has also 
been suggested that the peptidergic primary afferents may also play a role in the H2S-induced effects 
in smooth muscle tissues described in the urinary tract (Patacchini et al., 2004) and in isolated rat 
mesenteric arteries (White et al., 2013). According to in vitro experiments, Ca2+-signal could be 
detected upon H2S-stimulus in TRPA1-expressing CHO cells (Streng et al., 2008), moreover, the 
elevation of [Ca2+]i was absent after the application of the TRPA1 antagonist in dorsal root ganglion 
cells (Miyamoto et al., 2011). These data have raised the possibility, that capsaicin-sensitive sensory 




5. The relationship between the chronic complications of diabetes mellitus and the peptidergic 
primary afferents, as well as the problems of appropriate modeling of these complications 
In 2015, approximately 415 million people suffered from diabetes mellitus all over the world. One 
third of the patients develop diabetic neuropathy (DN) or diabetic nephropathy (DNP); the latter one 
is the leading cause of chronic kidney disease (Reutens and Atkins, 2011). Diabetic retinopathy (DR) 
occurs in 50-75% of the patients, and its development is correlating with both the duration of diabetes 
and the poor glycemic control (Yau és mtsai., 2012). The TRPV1 and TRPA1 receptors expressed on 
peptidergic afferent fibres, as well as SP and NKA released from the nerve endings participate in the 
development of neuropathic pain syndromes associated with diabetes (Coudoré-Civiale et al., 2000; 
Bölcskei et al., 2005; Koivisto et al., 2012). Besides, the importance of certain TRP ion channels and 
the antiinflammatory neuropeptide PACAP has been suggested in the pathomechanism of DNP 
(Colsoul et al., 2013; Bánki et al., 2013). During the formation of DR, several neuropeptides such as 
SP and CGRP as well as somatostatin and PACAP play an important role (Yang et al., 2013a,b; 
Szabadfi et al., 2014). In the preclinical development of drugs against chronic complications of 
diabetes it is strongly needed to use reliable animal models correlating with the alterations of the 
human disease. The main limitation of the usually applied experimental models is the poor health 
condition of the experimental individuals, rapidly developing in the absence of any antidiabetic 
therapy and leading to very short survival (Chen et al., 2005). In order to achieve the formation of 
detectable functional and morphological diabetes-related complications, the duration of diabetic state 
has to be extended long enough within the frame of such an experimental design that enables the 
tolerable general status of the animals parallelly. Another risk factor of the chronic complications of 
diabetes is the degree of hyperglycemia (Calcutt, 2004). The application of subcutaneously 
implantable sustained release insulin pumps provides good opportunity for the investigation of 
chronic glycemic state-dependent alterations by the establishment of several different glycemic states. 
 
6. The significance of sensory-immune interactions in the diseases of several organ systems 
Disorders of the interactions existing between the nervous and immune system have been investigated 
predominantly in neurological and autoimmune diseases; for instance, it is well-known that 
neurogenic inflammation participates in the pathogenesis of migraine, rheumatoid arthritis, allergic 
contact dermatitis and inflammatory bowel disases (Pintér és mtsai., 2014). However, increasing data 
are available suggesting that the defective functions of sensory-immune cooperation contribute to the 
development of the local vascular diseases of the skin (Aubdool and Brain, 2011), the formation of 
acute and chronic diseases of the respiratory system (Otmishi et al., 2008), as well as the development 






Capsaicin-sensitive sensory nerves, as well as TRP ion channels and neuropeptides expressed by both 
neuronal and non-neuronal structures may play an important role in several diseases of the vascular, 
respiratory and metabolic systems, providing potential pharmacological targets. Therefore, the 
appropriate animal modeling and the in vivo investigation of these mechanisms are essential. 
Our primary aims were the following: 
I. To investigate the role of capsaicin-sensitive primary afferents in the H2S-induced vasodilatory 
response of the skin. 
II. To analyse the involvement of the TRPA1 receptor in the mechanisms of acute and chronic 
inflammation of the airways.  
III. To examine the role of the Tac4 gene-encoded hemokinin-1 in the endotoxin-induced acute 
pneumonitis. 
IV. The setting and optimisation of a chronic rat model suitable for the investigation of the 
microvascular and sensory complications of diabetes. 
 
EXPERIMENTAL MODELS AND INVESTIGATIONAL TECHNIQUES 
 
1. Animals 
Microcirculatory investigations were performed on Balb/c, C57Bl/6 (Charles-River, Hungary) wild 
type, TRPA1 receptor gene-deficient (TRPA1-/-), TRPV1 receptor gene-deleted (TRPV1-/-, Jackson 
Laboratories, USA) and NK1 receptor gene-deficient (Tacr1-/-), as well as CGRP wild type 
(CGRP+/+) and CGRPgene-deleted (CGRP-/-) mice. In the acute and chronic airway 
inflammation models C57Bl/6, TRPA1+/+ wild type, as well as TRPA1-/- and Tac4 gene-deficient 
(Tac4-/-) mice were used. The original heterozygotic TRPA1+/- breeding pairs were donated by Prof. 
Pierangelo Geppetti (Firenze), whereas Tacr1-/- mice by Prof. John Quinn (Liverpool), and Tac4-/- 
mice by Alexandra Berger (Toronto). The induction of diabetes was carried out on Sprague-Dawley 
CFY rats. Animals were bred and kept in the Laboratory Animal House of the Department of 
Pharmacology and Pharmacotherapy and the Laboratory Animal House of the Medical School, 
University of Pécs, as well as the Laboratory Animal Centre of the King’s College, London at 24-




2. Protocols and methods applied during the investigation of microcirculation 
2.1. RTX-desensitization 
One group of C57Bl/6 mice was pre-treated with the ultrapotent TRPV1 agonist resiniferatoxin 
(RTX; 10, 20, 30, 70 and 100 μg/kg s.c. on 5 consecutive days). This leads to long-lasting 
defunctionalization of the capsaicin-sensitive nerve endings throughout the body (desensitization). 
The effect of systemic RTX-desensitization was checked 14 days later and considered satisfactory if 
capsaicin eye drops (50 μl 0.1%) did not cause eye-wiping movement (“wiping test”). 
2.2. Investigation of the molecular mediators of H2S-effects with the help of genetic and 
pharmacological tools 
The results of TRPA1-/-, TRPV1-/-, α-CGRP-/- and Tacr1-/- mice was compared to those of wild type 
controls. The selective TRPA1 receptor antagonist HC-030031 (30-100 mg/kg, i.p.), the CGRP 
receptor antagonist BIBN4096 (0.1-10 mg/kg, i.p.), the NK1 receptor antagonist CP99994 (10-50 
mg/kg, i.p.), the combination of BIBN4096 and CP99994, as well as the K+ATP-channel blocker 
glibenclamide (50 mg/kg, i.p.) were administered to Balb/c mice 30 min before the local application 
of NaHS. The results gained with these different treatments were compared to those of the vehicle-
treated group. 
2.3. Assessment of the cutaneous blood flow in the mouse ear 
The in vivo investigation of the microcirculation was performed with laser Doppler imaging technique 
(Periscan PIM-II; FLPI). Mice were anaesthetised with the combination of ketamine and xylazine 
(100 mg/kg, 5 mg/kg, s.c.) and colour-coded perfusion photos were taken of them. After taking three 
control images, the right ear was treated with NaHS, AITC, NaOH, NaSO3 or NaCl, whereas the left 
ear received respective vehicle. Changes of microcirculation were then recorded for 50 min in the 
case of NaHS-, NaOH-, NaSO3- and NaCl-treatments, and for 30 min in the case of AITC. For the 
quantitative evaluation of cutaneous blood flow, two regions of interest (ROIs) were determined 
representing the total area of the two ears. The changes of microcirculation are expressed in 
percentage of the initial control value. Areas under the blood flow curves (AUCs) demonstrate the 
total response of cutaneous blood vessels during the whole period of measurement. 
2.4. Induction of cutaneous vasodilatation in the mouse ear 
The increase of skin blood flow was elicited by treating the dorsal surface of the right ear with NaHS 
(15 μl, 5%, pH=12.61, dissolved in saline containing 1.25% methylcellulose) or AITC (15 μl, 2%, 
dissolved in liquid paraffin). In order to exclude the non-specific physico-chemical effects of pH and 
osmotic pressure, NaOH (15 μl, 0.16%, pH=12.61), NaSO3 (15 μl, 5%) and NaCl (15 μl, 5%) were 
also applied (all of them were prepared by using saline containing 1.25% methylcellulose as solvent). 




3. Methods applied in the acute and chronic airway inflammation models 
3.1. Endotoxin-induced acute airway inflammation 
Acute interstitial pneumonitis was elicited by intranasal (i.n.) inhalation of Escherichia coli (serotype: 
O83) endotoxin (lipopolysaccharide, LPS; 60 µl, 167 µg/ml), performed under light ether anaesthesia. 
Non-inflamed intact mice received the same volume of sterile phosphate buffered saline (PBS). 
3.2. Smoking-induced chronic airway inflammation 
Chronic airway inflammation was elicited by whole body cigarette smoke exposure. Mice were 
placed into the smoke exposure chamber (Teague Enterprises) twice daily, 10 times/week for 3 
months. For this purpose, “3R4F Kentucky Research Cigarette” was used, and the mice were exposed 
to cigarette smoke for 30 min followed by a ventilation period of another 30 min on every occasion. 
3.3. Functional investigation of airway responsiveness 
Airway responsiveness was determined by unrestrained whole body plethysmography (Buxco) in 
conscious, spontaneously breathing animals. In the endotoxin model, bronchoconstriction was 
elicited by increasing concentrations of aerosolized carbachol 24 h after PBS/LPS treatment, and we 
determined breathing frequency, as well as the enhanced pause (Penh) parameter correlating with 
bronchoconstriction and consequent airway resistance. In the cigarette smoke exposure model, 
changes of the airway function were measured monthly and breathing frequency, tidal volume (TV), 
peak expiratory flow (PEF) and Penh were determined. 
3.4. Bronchoalveolar lavage 
In the cigarette smoke exposure model, the lungs of the ketamine-xylazine (100 mg/kg, 5 mg/kg, s.c.) 
anaesthetized mice were flushed with 5x1 ml PBS with the help of a trachea cannula. Cell profile of 
the collected bronchoalveolar lavage fluid (BALF) samples were analyzed with CyFlow Space flow 
cytometer (Partec). 
3.5. Histological examination of the lungs 
Lung samples were fixed, embedded in paraffin, sectioned and stained with hematoxylin-eosin (HE) 
or periodic acid-Schiff (PAS) reaction. Semiquantitative evaluation of the inflammatory changes was 
performed by an expert pathologist blinded from study. Score values were given on the basis of 
certain histopathological parameters defined separately for the acute and chronic models. These 
parameters were then added to create composite inflammatory score. 
3.6. Determination of myeloperoxidase (MPO) enzyme activity from lung homogenates 
MPO activity of the lung homogenates correlating with the count of neutrophil granulocytes and 
macrophages was measured by spectrophotometry. 
3.7. In vivo bioluminescence imaging of myeloperoxidase activity 
Bioluminescence of the luminol analogue L-012 is proportional to the ROS/RNS production during 
acute pneumonitis, which was determined with IVIS Lumina II (PerkinElmer) device 24 h after 
PBS/LPS-treatments. During the quantitative evaluation, the luminescent sign intensity of each ROI 
was expressed as total radiance (foton flux/s). 
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3.8. Measurement of the cytokine concentrations of the lung homogenates 
Lung samples were homogenized, centrifuged and the concentrations of inflammatory cytokines were 
determined with the help of Luminex xMAP technique. The results are given in pg/g wet tissue. 
 
4. Protocols and methods applied in long-term modeling of diabetes 
4.1. Treatment protocols 
Diabetes was induced by single injection of 60 mg/kg streptozotocin (STZ, i.p.). Blood glucose levels 
were checked 48 h after STZ-injection and rats with blood glucose over 14 mmol/l were involved in 
the study and divided into 4 groups. Diabetic 1, 2 and 3 groups received s.c. implantable insulin 
implants (Linplant 2 NE/24 h, LinShin): the Diabetic 1 group got 1 + 1, the Diabetic 2 group got 1 + 
0.5, whereas the Diabetic 3 group got 0.5 + 0.5 implants on Weeks 1 and 9. The animals of the 
Diabetic 4 group received 2 IU Humulin N (i.p.) intermediate-acting insulin injection every second 
day. Control animals got vehicle (citrate buffer, i.p.) at the beginning of the experimental period, and 
blank implants (Palmitic Acid Micro Crystal) on Weeks 1 and 9. Investigation of the animals could 
be performed for 12 weeks after the induction of diabetes in case of the Diabetic 4 group, and for 16 
weeks in the other groups. 
4.2. Monitoring of blood glucose level, body weight, as well as food and water consumption 
Blood samples, collected from the tail vein, were tested by Accu-Check Active blood glucose tester 
twice a week in the diabetic groups and once a month in the Controls. Body weight changes were 
recorded twice and once a week in the Diabetic and the Control groups, respectively. Relative food 
and water consumption were measured once a week and daily, respectively. These in vivo data were 
compared to the starting values recorded on one occasion during the pretrial period. 
4.3. Eye examination and ophthalmoscopy 
In vivo investigation of the eyes was carried out in ketamine-diazepam (30 mg/kg ill. 3 mg/kg) 
anaesthesia, and the pupils were dilated with 5 mg/ml tropicamide. Colour photos of the anterior 
segment – including cornea and iris - were taken. The proportion of the area affected by 
neovascularization was calculated. For histological examination of the cornea, eyes were fixed, 
embedded into paraffin, sectioned and stained with HE. Posterior pole of the eye was investigated 
with an indirect binocular ophthalmoscope (IBO) connected to a computer (Optibrand Clear View 
optical imaging system, USA); The evaluation of the retina was performed by semiquantitative 
scoring on the basis of certain pre-defined parameters. These parameters were then added to assess 
the composite Total Retinal Score (TRS) value. 
4.4. Histology and immuno-histochemistry of the retina 
For histological examination, eyes were fixed in 4% paraformaldehyde and embedded into Durcupan 
ACM resin. Semi-thin (2 µm) sections were stained with toluidine blue and morphometric analysis 
of the samples was performed. Immuno-histochemistry was carried out on another group of samples 
using the following antibodies: anti-tyrosine-hydroxylase (TH), anti-glial fibrillar acidic protein 
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(GFAP) and anti-Brn3a antibodies, as well as FITC-conjugated peanut agglutinin (PNA). Colour 
photos taken during the microscopic examination were evaluated qualitatively and quantitatively. A 
third group of samples served for the determination of apoptotic cell amount with the help of TUNEL 
assay. 
4.5. Urine analysis 
In order to collect urine samples, animals were individually housed in metabolic cages for 16 h and 
deprived of food during sampling. Samples were centrifuged at room temperature (6000 rpm, 5 min) 
and the supernatants were stored at -20°C. Concentrations of creatinine and total protein were 
measured. 
4.6. Histology of the kidneys 
Kidney samples were fixed in 4% formaldehyde and embedded into paraffin; the 3 µm sections were 
stained with HE and PAS. Following microscopic investigation, the proportion of PAS-positive 
glomerular area related to the total glomerular area was calculated. Another group of the samples was 
fixed in absolute alcohol, and the sections were stained with PAS- and diastase digested PAS-reaction 
in order to prove the glycogen content of tubular granules (Armanni-Ebstein phenomenon). 
4.7. Electron microscopic investigations 
Samples of the eyes and kidneys were fixed in 4% paraformaldehyde supplemented with 
glutaraldehyde, treated with OsO4, dehydrated and embedded in Durcupan ACM resin or Araldit. 
Ultra-thin (70 nm) sections were cut and counter-stained with Reynold’s lead citrate. Samples were 
photographed during electron microscopic investigation. 
4.8. Investigation of mechanosensitivity and cold allodynia 
Touch senstivity of the plantar surface of the hindpaws was measured by dynamic plantar 
aesthesiometry (Ugo Basile). Since this mechanical stimulus is not painful in rats, the drop of the 
mechanonociceptive threshold is regarded as allodynia. Pressure senstivity of the hindpaws was 
determined with Randall-Selitto test using the Ugo Basile analgesimeter. Since this stimulus is painful 
in rats, the drop of this mechanonociceptive threshold is considered as hyperalgesia. Cold allodynia 
was investigated by immersing the hindpaw or the tail into 0°C water, and assessed by the latency 
time of withdrawal reaction (cut-off time was 180 sec). 
 
Statistical analysis 
The results of microcirculation measurements were analyzed with unpaired t-test or one-way 
ANOVA followed by Bonferroni’s post hoc test. The evaluation of airway function parameters, MPO 
activity, total flux values and cytokine concentrations was performed with one- or two-way ANOVA 
+ Bonferroni’s post test. Composite inflammation scores were analyzed with Kruskal-Wallis test 
followed by Dunn’s post test. The results of the diabetic animals were evaluated with one-way 





All experiments were performed according to the 1998/XXVIII Act of the Hungarian Parliament on 
Animal Protection and Consideration Decree of Scientific Procedures of Animal Experiments 
(243/1988), as well as the European Parliament and Council Directive of 2010/63/EU. The studies 
were approved by the Ethics Committee on Animal Research of the University of Pécs and by the 
King’s College London Animal Care and Ethics Committee (license No. BA 02/2000-2/2012, PPL 
No. 70/7959). 
 
RESULTS AND DISCUSSION 
 
I. Investigation of the role of capsaicin-sensitive primary afferents, as well as the sensory 
neuropeptides in the H2S-induced vasodilatation 
 
Results 
Capsaicin-sensitive primary afferents play an important role in the H2S- and AITC-induced 
vasodilatation 
In C57Bl/6 mice, NaHS continously increased the cutaneous microcirculation of the ear during the 
total examination period (42% increase in perfusion at 48 min). The vasodilatory effect of NaHS was 
significantly attenuated by RTX-desensitization: the decline of the total vascular response was 41.5%. 
The RTX-pretreatment significantly decreased the AITC-induced vasorelaxation as well. 
TRPA1 and TRPV1 are differently involved in NaHS- and AITC-evoked vasodilatation 
In TRPA1-/- mice, the increase of microcirculation elicited by NaHS was significantly lower than in 
the C57Bl/6 group: the total vascular response was decreased by 47%. On the contrary, there was no 
difference between the blood flow changes of the TRPV1-/- and C57Bl/6 mice. AITC-induced 
vasodilatation was totally absent in the TRPA1-/- group, but in the TRPV1-/- mice it was similar to 
that of the C57Bl/6 group. 
The TRPA1 receptor antagonist inhibits the NaHS- and AITC-induced vasorelaxation 
Vasodilatation elicited by NaHS was greater in Balb/c mice than in the C57Bl/6 group (67% increase 
in perfusion at 48 min). HC-030031 attenuated the increase of skin blood flow significantly and in a 
concentration-dependent manner. The two different doses of the antagonist decreased the total 
vascular response by 24.6% and 51.4%. HC-030031 also attenuated AITC-induced vasorelaxation 
significantly. 
CGRP plays an important role in the H2S-induced increase of cutaneous microcirculation 
The NaHS-evoked increase of microcirculation was significantly lower in the α-CGRP-/- mice than in 
the α-CGRP+/+ animals: the total vascular response was 55.5% lower in the absence of α-CGRP. 
BIBN4096 decreased NaHS-induced vasodilatation significantly and in a concentration-dependent 
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manner: the dose of 0.1 mg/kg caused only tendentious, but the higher doses (> 1 mg/kg) caused 
significant difference. 
The activation of NK1 receptor contributes to the development of H2S-evoked vasodilatation 
NaHS-induced vasodilatation was significantly lower in the Tacr1-/- mice than in the wild types. The 
total vascular response was 48.2% lower in the absence of NK1 receptor. Attenuation of the NaHS-
evoked increase of blood perfusion was significant and concentration-dependent: the lower dose (10 
mg/kg) did not, but the higher doses (> 25 mg/kg) did significantly decrease the vasorelaxation. 
The effect of simultaneous blockade of CGRP és NK1 receptors on H2S-induced vasodilatation 
Combined treatment with BIBN4096 and CP99994 resulted in a significant decline of NaHS-evoked 
vasodilatation. The initial phase of the vasodilatory response resembled the single inhibition of the 
NK1 receptor, whereas the second phase of the reaction was rather similar to the inhibition of the 
CGRP receptor. 
K+ATP-channels are also involved in the H2S-induced vasodilatation 
The K+ATP-channel blocker glibenclamide significantly attenuated the increase of skin blood flow 
elicited by NaHS. The kinetics and extent of the inhibitory effect was similar to the decrease of 
vasorelaxation after the treatment with HC-030031. 
The pH and osmotic pressure do not influence cutaneous microcirculation 
The effects of NaOH, NaSO3 and NaCl on cutaneous microcirculation were significantly lower than 




In the present study we have provided clear in vivo evidence that capsaicin-sensitive sensory nerves 
play a major role in the mediation of H2S-induced vasodilatation. The role of primary sensory 
afferents in the vascular effects of H2S was investigated in vitro by White et al. (2013), and the data 
of their isolated organ experiments are in accordance with our present results obtained in the mouse 
ear microcirculation model. Previous data suggested that the TRPA1 receptor expressed on sensory 
nerve endings is involved in the mediation of neuronal (Pozsgai et al., 2010; Kunkler et al., 2011; 
Aubdool et al., 2014) and endothelium-dependent vasodilatation (Earley et al., 2009). The hypothesis, 
that H2S may activate TRPA1, was first proposed based on in vitro experiments (Streng et al., 2008; 
Miyamoto et al., 2011). Our present in vivo results clearly demonstrate that the activation of TRPA1 
plays a key role in the H2S-evoked increase of cutaneous microcirculation, highlighting that the 
TRPA1 receptor should be considered as an important mediator of the vasoactive effects of H2S. The 
potential molecular mechanism of the interaction between H2S and TRPA1 might be the S-
sulfhydration of the cysteine residues found on the ion channel (Macpherson et al., 2007; Mustafa et 
al., 2009); the intermediate species of this process are presumably polysulfide compounds generated 
in aqueous solutions of H2S (Greiner et al., 2013; Hatakeyama et al., 2015). On the other hand, 
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specific disulfide bonding between critical cysteine residues and major conformational changes on 
the N-terminus might also contribute to the activation of TRPA1 (Eberhardt et al., 2014). Concerning 
the role of TRPV1 receptor in H2S-induced activation of sensory nerves, contradictory data are 
available in the literature (Trevisani et al., 2005; Miyamoto et al., 2011). According to our results, the 
extent of vasodilatation was identical in TRPV1-/- mice and in wild types, suggesting that the TRPV1 
receptor does not participate in the mediation of H2S-induced vasodilatory response. These in vivo 
results have been confirmed by other members of our workgroup with the help of radioactive 45Ca2+-
uptake experiments performed on TRPA1 as well as TRPV1 receptor expressing CHO cells. It is also 
known that not only TRPA1, but also CGRP takes part in the mediation of 4-ONE-induced 
vasorelaxation (Graepel et al., 2011). On the basis of in vitro data, it also has been suggested that 
CGRP may be involved in the H2S-evoked smooth muscle relaxation and vasodilatation (Fernandes 
et al., 2013; Eberhardt et al., 2014). Moreover, H2S has also been proposed to elicit acute pneumonitis 
in a SP- and NK1 receptor-dependent manner (Bhatia et al., 2006), raising the possibility that the NK1 
receptor mediated signaling pathway may also contribute to the H2S-evoked increase of 
microcirculation. Our present study provides clear in vivo evidence that both CGRP and SP are 
important mediators of H2S-induced cutaneous vasorelaxation. Combined treatment with the CGRP 
and NK1 receptor antagonists did not result in an additive effect, however, the inhibition of H2S-
evoked microcirculatory changes was similar to the NK1 receptor inhibition in the first 10-15 min, 
and resembled the CGRP receptor inhibition in the later phases of the experiment. Our observations 
can be explained by faster cell signaling in the case of NK1 receptor activation, but potentially 
different pharmacokinetic characteristics of the two antagonists cannot be excluded. Regarding the 
role of K+ATP-channels in the relaxation of blood vessels and other smooth muscle tissues, conflicting 
results have been published (Fernandes et al., 2013; White et al., 2013; Eberhardt et al., 2014). Our 
present findings show that K+ATP-channels of vascular smooth muscle cells also contribute to the H2S-
induced relaxation of skin arteries. Since glibenclamide-sensitive K+ATP-channels have been shown 
to be involved in the mediation of certain CGRP effects (Santicioli and Maggi, 1994), the interaction 
between capsaicin-sensitive sensory nerves and K+ATP-channels is also presumable in the molecular 
mechanisms of H2S-induced cutaneous vasodilatation. Although alkaline pH has been proposed to 
activate TRPA1 receptors (Fujita et al., 2008), we did not experience any changes in response to high 
pH or osmotic effects, suggesting that these non-specific physico-chemical stimuli do not influence 
the microcirculatory effects of H2S. It can be concluded that the activation of capsaicin-sensitive 
primary afferents through the TRPA1 receptor, as well as the vasoactive neuropeptides released from 






II. Involvement of the TRPA1 receptor in acute and chronic airway inflammations 
 
Results 
TRPA1 exerts protective function in the endotoxin-induced airway hyperreactivity 
Penh was increased upon LPS stimulation in both TRPA1+/+ and TRPA1-/- mice in a concentration-
dependent manner, indicating the development of inflammatory airway hyperreactivity. Bronchial 
hyperresponsiveness was significantly greater in TRPA1-/- mice than in the wild types. LPS-treatment 
caused a significant decrease of the baseline value of breathing frequency in both TRPA1+/+ and 
TRPA1-/- mice. Carbachol inhalation evoked a concentration-dependent decline of breathing 
frequency in the TRPA1-/-, but not in the TRPA1+/+ group. 
TRPA1 plays an important role in the increase of inflammatory MPO activity of the lung 
Basal activity of the MPO enzyme was practically the same in the two control groups. The treatment 
with endotoxin resulted in a remarkable increase of the MPO activity, which was significantly greater 
in mice lacking TRPA1 than in the wild types. 
TRPA1 is not involved in the endotoxin-induced histopathological alterations of the lung 
LPS-treatment caused significant perivascular/peribronchial edema, inflammatory cell accumulation 
and goblet cell hyperplasia in wild type mice compared to the PBS-treated groups. These 
histopathological alterations were similar in the TRPA1+/+ and TRPA1-/- animals. 
TRPA1 does not influence cigarette smoke-induced changes of the airway function parameters 
Breathing frequency was significantly decreased in both TRPA1+/+ and TRPA1-/- mice from the first 
month of cigarette smoke exposure. Between the frequency values of the two animal groups no 
significant difference could be observed at any time point. TV, PEF and Penh did not alter 
significantly during the 3-month examination period. 
TRPA1 plays a complex role in the cigarette-smoke induced inflammatory changes of the lung 
In the first month of the smoke exposure model, remarkable perivascular edema developed in both 
examined mouse groups which gradually and significantly decreased in the second and third months. 
This parameter showed no difference between the TRPA1+/+ and TRPA1-/- mice. However, the 
amount  of  accumulating  neutrophil  granulocytes  was  greater in the first month, whereas the extent 
of macrophage  infiltration  and  alveolar-interstitial  edema  was  lower  in  the  second  month in the 
TRPA1-/- strain compared to the wild types. 
Accumulation of lymphocytes is increased in the absence of the TRPA1 receptor 
The amount of lymphocytes in the bronchoalveolar lavage fluid was tendentiously higher at the end 
of the second month, however, it was significantly greater at the end of the third month in TRPA1-/- 
mice compared to the wild types. There was no difference in the amount of neutrophils and 





The TRPA1 receptor has been suggested to take part in the development of several airway diseases 
(e.g. bronchial asthma, COPD) (Grace et al., 2014), but data concerning its activation mechanisms 
and its precise pathophysiological role are few and contradictory. In our present study, we have 
provided evidence that the TRPA1 receptor exerts clear protective effects in the bronchial 
hyperreactivity as well as the granulocyte- and macrophage-derived MPO production associated with 
endotoxin-induced acute pneumonitis. Although some recent publications suggested that TRPA1 
could mediate bronchoconstriction in different asthma models (Jha és mtsai, 2015; Devos és mtsai., 
2016), our observation demonstrating the protective role of TRPA1 during acute inflammation is 
confirmed by previous investigations of our workgroup, where the activation of peptidergic primary 
afferents through the TRPV1 receptor exerted protective effects in the development of endotoxin-
induced acute airway inflammation and consequent bronchial hyperresponsiveness (Elekes et al., 
2007; Helyes et al., 2007). The similar functions of the two ion channels are not surprising, since they 
are co-expressed on the sensory nerve endings, and their physical and functional interaction is also 
presumable (Lee et al., 2015). The TRPA1-mediated protective effects can be explained with the 
release of antiinflammatory neuropeptides (e.g. somatostatin) from the primary sensory afferents 
(Helyes et al., 2009). Previous in vitro data suggested that the cigarette smoke extract (CSE) causes 
CGRP- and SP-release from peptidergic sensory nerves, as well as that TRPA1 takes part in the 
formation of CSE- or nicotine-induced plasma extravasation and bronchoconstriction (André et al., 
2008; Talavera et al., 2009). Besides, ROS and several lipid peroxydation products generated in 
oxidative stress associated with COPD are also able to activate this ion channel (Bessac és Jordt, 
2008). In the present in vivo model of chronic cigarette smoke exposure we found that the 
histopathological picture of the first month (acute phase, dominated by peribronchial and perivascular 
edema) changed in the second month (intermediate phase) and it was then characterized by infiltration 
of inflammatory cells, in accordance with the newest results of our workgroup (Kemény et al., under 
review). Furthermore, our present results provided evidence that in the TRPA1-/- mice the 
accumulation of granulocytes was significantly higher in the first month, whereas macrophage-
dominated cell infiltration and alveolar-interstitial edema was significantly lower at the end of the 
second month. These results suggest that the activation of TRPA1 exerts protective effects in the 
acute phase of the cigarette smoke-evoked airway inflammation, but later it presumably contributes 
to the progression of inflammation as a member of the proinflammatory cascade. The possible 
explanation of this observation is that the transient activation of TRPA1 by toxic irritants of the 
cigarette smoke typically induces protective reflexes, but the permanent stimulation of the receptor 
by its endogenous activators produced under chronic inflammatory conditions continously maintains 
the neurogenic inflammation state (Chen et al., 2012). On the other hand, beside the capsaicin-
sensitive sensory nerves TRPA1 is also expressed on non-neuronal cells, e.g. on macrophages (Kun 
et al., 2017), and the stimulation of TRPA1 on different structures may activate different intracellular 
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signaling mechanisms leading to diverse outcomes in certain phases of chronic inflammation. Since 
the absence of TRPA1 receptor resulted in an increased accumulation of lymphocytes in the third 
month of cigarette smoke-exposure (lymphocyte-dominated chronic phase), and since the ion channel 
is also expressed on lymphocyte cells (Stokes et al., 2006), it is presumable that the TRPA1 receptor 
plays a regulatory role in the functions of lymphocytes as well. The complex investigation of airway 
function performed in our study showed that these parameters are not influenced by activation of 
TRPA1, therefore we cannot confirm the hypothesis based on in vitro data that suggested a mediator 
role for the receptor in the cigarette smoke-induced changes of airway function. Nevertheless, it is 
important to note that H2S exerts antiinflammatory and bronchodilatory effects in chronic smoke 
exposure (Chen et al., 2011). The fact that not only the toxic irritants of cigarette smoke are able to 
activate TRPA1 but also the gaseous mediator H2S (see Results and discussion/Chapter I), raises the 
possibility of an interaction between the different signaling pathways at this point. Therefore, the role 
of TRPA1 in the development of chronic bronchitis seems to be much more complicated than it was 
supposed before. Moreover, since our experiments proved the protective function of the ion channel 
in endotoxin-induced acute pneumonitis, it is strongly presumable, that the activation of capsaicin-
sensitive sensory neurons and inflammatory cells through the TRPA1 receptor results in complex 
modulatory effects during the acute and chronic inflammatory processes of the lung. 
 
III. Investigation of the role of HK-1 in endotoxin-induced acute pneumonitis 
 
Results 
HK-1 does not influence endotoxin-induced airway hyperreactivity 
In comparison with the PBS-treated controls, Penh value of the LPS-treated mice showed a significant 
and concentration-dependent increase. This airway hyperreactivity was similar in the Tac4-/- mice and 
in the wild types. Breathing frequency decreased in both LPS-treated groups in a concentration-
dependent manner, and no difference was detectable between the Tac4-/- and wild type mice. 
HK-1 exerts proinflammatory effect in the endotoxin-evoked histological alterations of the lung 
One day after the treatment with endotoxin, remarkable peribronchial/perivascular edema, neutrophil 
accumulation, mononuclear cell infiltration and goblet cell hyperplasia developed in wild type mice. 
The severity of inflammation was significantly reduced in the Tac4-/- group. In the lung samples of 
LPS-treated Tac4-/- mice, large, dense, follicle-like lymphoid structures were detectable 
peribronchially and perivascularly. This feature could not be observed either in the wild types or in 
other knockout strains examined previously by our workgroup. 
HK-1 plays an important role in the neutrophil-derived MPO activity in the lung 
In the LPS-treated mouse groups, bioluminescent sign intensity of the lungs was remarkably 
increased compared to the PBS-treated mice. The lungs of the LPS-treated Tac4-/- mice showed 
significantly lower bioluminescence compared to the wild types. 
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HK-1 enhances myeloperoxidase activity in the lung 
MPO activity was significantly higher in the wild type mouse lungs 24 h after LPS inhalation. In the 
Tac4-/- mice, MPO activity was attenuated in comparison with that of the wild type mice. 
HK-1 increases the proinflammatory cytokine production in the lung 
In wild type mice, the levels of all examined cytokines remarkably elevated 24 h after the treatment 
with LPS. The concentrations of IL-1β, IL-6, KC, TNFα and MCP-1 were reduced significantly, 




We have provided here the first evidence that HK-1 plays an important role in the development of 
endotoxin-induced interstitial pneumonitis. Our experiments revealed that edema formation and 
inflammatory cell accumulation as well as the neutrophil granulocyte- and macrophage-derived MPO 
activity were significantly reduced in the absence of HK-1. However, previous investigations of our 
workgroup demonstrated that the lack of NK1 receptor caused no alterations in these parameters 
(Helyes et al., 2010). On the basis of these results, it can be concluded that HK-1 plays an important 
role in the acute inflammatory processes of the lung, but this effect is not mediated by the NK1 
receptor. Our present findings are in accordance with the results of our workgroup gained in chronic 
murine arthritis, showing that the development of joint inflammation is independent from NK1 
receptor activation (Borbély et al., 2013). Therefore, our results strongly support the existence of 
another, specific receptor for HK-1 mediating inflammatory actions at the periphery. Since the results 
of MPO activity measurements and bioluminescent imaging of ROS showed perfect correlation in 
our model, it is strongly presumable that the luminescent sign intensity of the lung developed due to 
the activation of MPO. It is known that numerous proinflammatory cytokines are released during the 
LPS-evoked inflammatory reaction (e.g. TNFα, IL-1β, IL-6, KC) and the relation between HK-1 and 
the cytokine system was also suggested based on in vitro investigations (Berger et al., 2007). The 
results of our present in vivo experiments clearly show, that the LPS-induced elevation of 
proinflammatory  cytokines  is  significantly  attenuated  in  the  Tac4-/-  mice,  further  indicating that 
HK-1 plays a crucial role in cytokine release and consequent immune cell activation during 
pulmonary inflammation. Since the large, dense, follicle-like structures associated to the vessels and 
bronchi were observed only in the lungs of LPS-treated Tac4-/- mice and were not detectable in other 
previously examined knockout mouse strains, it can be presumed that HK-1 also contributes to the 
regulated activation of lymphocytes under pathophysiological conditions. This first in vivo 
observation is supported by the earlier described B-lymphopoesis promoting effect of HK-1 (Berger 
et al., 2010). In contrast to the previously published role of SP and NKA (Helyes et al., 2010), and in 
contrast to the mediator function of HK-1 in peripheral inflammatory reactions, HK-1 does not 
influence airway hyperreactivity. Although hHK-1 has been suggested to evoke bronchoconstriction 
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(Grassin-Delyle et al., 2010), we could not confirm a similar effect for HK-1 in this murine model of 
acute pneumonitis. One explanation for this contradiction is that hemokinins and endokinins make 
up a more complicated system in humans than in mice: the human TAC4 gene has four different 
splice variants, and their sequences are different from their murine counterparts, moreover, they also 
show different expression characteristics (Page, 2004). Another explanation is that the inflammatory 
bronchoconstriction is predominantly mediated by the NK2 receptor (Elekes et al., 2007; Helyes et 
al., 2010), but HK-1 shows remarkably lower affinity to the NK2 receptor, than it does to the NK1 
(Bellucci et al., 2002). In summary, we have demonstrated the first data for an important mediator 
role of HK-1 in airway inflammation. Furthermore, HK-1 seems to have a specific regulatory role on 
lymphocyte functions under inflammatory conditions, the precise mechanism of this process needs 
further investigation. 
 




The changes of blood glucose level, body weight, as well as water and food consumption 
Blood glucose level of the Control rats was 5-7 mmol/l during the total examination period. Average 
blood glucose level was 8-10 mmol/l in the Diabetic 1 group, 16-18 mmol/l in the Diabetic 2 group, 
22-25 mmol/l in the Diabetic 3 group, and it reached 30-33 mmol/l in the Diabetic 4 group. Weight 
gain of the Diabetic 1-3 groups was slightly less than that of the Controls, whereas in the Diabetic 4 
group a weight loss of 13.4% was observed instead of the physiological weight gain. Relative water 
and food consumption was markedly increased in the Diabetic 3-4 groups. The results of the Diabetic 
3-4 groups showed statistically significant differences in all parameters compared to the Controls. 
Neovascularization of the anterior segment and the pathological changes of the posterior pole 
Diabetic 3-4 animals developed remarkable anterior segment neovascularization. The severity of 
neovascularization was significantly greater in the Diabetic 4 group, than it was in the Diabetic 2-3 
animals. The TRS was significantly elevated in the Diabetic 2-4 groups compared to the Control and 
Diabetic 1 animals, moreover, TRS values of the Diabetic 3-4 groups were significantly higher than 
that of the Diabetic 2 group. 
Histological alterations of diabetic retinopathy 
In Diabetic retinas, a slight decrease of the OLM-ILM distance, as well as of the OPL and IPL widths 
was detectable compared to the Controls. Besides, the total number of cells and the ganglion cell 
number were significantly reduced in 100 µm GCL. GFAP immunoreactivity of the retina was 
increased in all Diabetic groups. The amount of cone terminals in the OPL was significantly lower in 
the Diabetic 2-4 groups than in the Control animals. Processes of the dopaminergic amacrine cells 
were remarkably thinner in the Diabetic 3 and 4 groups, moreover, in the latter one they were even 
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absent. The number of TUNEL-positive cells was significantly higher in the Diabetic 3-4 groups than 
in the Control retinas, the extent of apoptosis was most severe in the ONL. Besides, the degeneration 
of the pigment epithelium, as well as blood vessels extending into the retina from the choroid were 
detected. Glial cell membranes forming the tight junctions of the ILM were separated in the Diabetic 
3 retinas, moreover, the degeneration of the IPL was also especially notably in this group. In the retina 
samples of the Diabetic 3-4 groups, macrophages were observable in the OPL, INL and IPL as well 
as microglial cells in the IPL. 
Histological alterations of diabetic nephropathy 
The relative ratio of the PAS-positive glomerular area was significantly increased in all Diabetic 
groups compared to the Controls, moreover, the glomerular PAS-positivity in the Diabetic 4 animals 
was significantly higher than in any other examined group. The presence of the Armanni-Ebstein 
phenomenon could be detected in the Diabetic 2-4 animals. Besides, segmental thickening of the 
glomerular basement membrane, multifocal fusion of the podocyte foot processes and expansion of 
the mesangial matrix were also observed. 
Urine investigations for the detection of DNP 
At the end of the examination period, the excreted urine amount was significantly higher in the 
Diabetic 2-3 groups than in the Control and Diabetic 1 animals (polyuria). In Diabetic 4 rats, after an 
initial polyuric phase, the urine amount declined by the end of the experiment (threatening anuria). 
The total protein/creatinine ratio slightly increased in the Diabetic 1-2 groups. In Diabetic 3 and 4 
rats, this ratio changed differently: it was remarkably elevated at the middle time point of the 
experiment, but markedly decreased by the end of the examination period. 
Mechanical hyperalgesia and cold allodynia 
The mechanonociceptive thresholds in touch and pressure sensitivity, as well as the withdrawal 
latency from 0°C water of the hindpaws were significantly reduced in all Diabetic groups compared 
to the Controls. These changes were similar in Diabetic 1-3 animals, however, the tail withdrawal 
latency from ice-cold water was hyperglycemia-dependent. 
 
Discussion 
In our present study we tested different insulin treatment protocols in order to keep diabetic animals 
in relatively good condition but to allow different levels of hyperglycemia to remain for a long time. 
For this purpose, we performed targeted glycemic control with the help of sustained release insulin 
implants (Havel et al., 2000). Our findings provide clear evidence that the anterior segment 
neovascularization, as well as retinal alterations defined with TRS proved to be glycemic state-
dependent. During the development of DR, the damaged inner blood-retinal barrier results in 
microaneurysms and intraretinal bleeding. Besides, it is presumable that the increased production of 
vascular endothelial growth factor (VEGF) is responsible for the neovascularization affecting both 
the anterior and posterior segments of the eye (Klaassen et al., 2013). In contrast to the physiological 
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GFAP expression selectively localized to the end feet of Müller glial cells, we observed increased 
GFAP immunoreactivity in the entire retina of Diabetic 3 rats indicating severe metabolic damage of 
the retina (Chang et al., 2007). Malfunctioning cellular metabolism leads to apoptosis of the retinal 
neurons (Szabadfi et al., 2014). The present study also showed that not only the cone terminals of the 
photoreceptors were degenerated in the Diabetic 3 rats, but also dopaminergic amacrine cells which 
retinal cell type is most sensitive to diabetic changes. Furthermore, our investigations also revealed 
that the amount of TUNEL-positive apoptotic cells is proportional to the severity of hyperglycemia. 
Severe alterations of synaptic profiles and open glial tight junctions in the ILM results in easy access 
to the retinal structures for migrating immunocompetent cells. The apoptosis and degeneration of 
retinal cells led to remarkable thinning of the retina corresponding to the later phase of human diabetes 
(Takahashi and Chihara, 2008). In the present study we observed remarkable glomerular PAS 
positivity, increased tubular glycogen accumulation, mesangial matrix expansion, segmentally 
thickened glomerular basement membrane, as well as podocyte foot effacement in the kidney samples 
of the Diabetic 3 animals, which alterations are also characteristic for human DNP (Dronavalli et al., 
2008). The elevation of the urine total protein/creatinine ratio in the initial phase of the examination 
period and its subsequent decrease in the later phase correlates with the clinical experience in human 
diabetic patients suffering from end-stage renal failure. This apparent improvement of proteinuria 
occurs as a sign of serious glomerular damage and occlusion. From the examined parameters of DNP 
both glomerular PAS-positivity and urine total protein/creatinine ratio showed glycemic state-
dependence. Human DN occurs mostly as distal symmetrical polyneuropathy and often causes 
hyperalgesia and allodynia (Sun et al., 2012). Major contributing factor of the development of DN is 
hyperglycemia, but the defective direct signaling of insulin and the possible effects of STZ on sensory 
neurons has also been postulated in rodents (Brussee et al., 2004; Pabbidi et al., 2008). Since cold 
allodynia of the tail was clearly hyperglycemia-dependent, the investigation of this parameter could 
be a reliable opportunity for the evaluation of diabetic neuropathy associated with long-term 
continous or intermittent hyperglycemia. In summary, the application of different “doses” of insulin 
implants enabled the setting of different degrees of hyperglycemia severity, and consequently the 
investigation of several hyperglycemia-dependent pathological conditions. In our complex series of 
experiments, the Diabetic 3 animals have been proved to be the most suitable model of chronic 
complications, where the alterations of the eye, kidneys and peripheral nervous system could be 




SUMMARY OF THE NOVEL FINDINGS 
I. We have provided first in vivo evidence, that the capsaicin-sensitive sensory nerve endings 
play a crucial mediator role in the H2S-induced vasodilatation of the skin. H2S exerts its 
vasodilatory effects through the activation of the TRPA1 receptor expressed on the sensory fibres, 
whereas the TRPV1 receptor does not participate in this process. CGRP and SP released from 
activated peptidergic primary afferents play a key role in the H2S-evoked increase of local 
microcirculation. Activation of the K+ATP-channels also contributes to the formation of vasodilatation 
elicited by H2S, but pH and osmotic effects do not influence this vascular response. 
II. The present results clearly demonstrate, that the TRPA1 receptor mediates complex regulatory 
effects in the acute and chronic inflammatory processes of the lung. TRPA1 plays a protective 
role in the development of acute bronchial hyperreactivity, as well as in the activation of neutrophil 
granulocytes and mononuclear cells, similarly to the previously described functions of the TRPV1 
receptor. Furthermore, during the progression of cigarette smoke-induced airway inflammation, 
TRPA1 has a complex role in the regulation of granulocyte-, macrophage- and lymphocyte-functions, 
as well as the formation of the alveolar-interstitial edema. Activation of the receptor does not affect 
airway function. 
III. We have provided here the first evidence for the proinflammatory functions of HK-1 in 
acute interstitial pneumonitis. HK-1 enhances the accumulation and activation of neutrophil 
granulocytes and macrophages, as well as the production of proinflammatory cytokines in the lung. 
Moreover, our observations raised the possibility that HK-1 is involved in the regulation of 
lymphocyte functions, but its precise mechanism needs further investigation. HK-1 has no influence 
on inflammatory airway hyperreactivity. 
IV. Our present study characterized a preclinical model that is suitable for long-term and 
parallel evaluation of diabetic eye disorders, nephropathy and neuropathy. The 
neovascularization of the anterior segment, the Total Retinal Score, the amount of apoptotic cells in 
the retina, the glomerular PAS-positivity, the urine total protein/creatinine ratio and the cold allodynia 
were proven to be hyperglycemia-dependent, and the quantitative analysis of these parameters could 
serve as an essential step in the preclinical development of drugs against chronic diabetic 
complications. 
The disorders of sensory-immune interactions are involved in the development of certain vascular, 
respiratory and metabolic diseases. Detailed identification of the molecular targets participating in 
these processes strongly promote the development of novel drugs affecting the interactions between 
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